3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Urinary Bladder Neoplasms
5
Neoplasm Metastasis
3
Carcinoma, Merkel Cell
3
Urethral Neoplasms
1
Ureteral Neoplasms
1
Thymoma
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Skin Neoplasms
1
Prostatic Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Muscle Invasive Bladder Urothelial Carcinoma
1
Melanoma
1
Lymphatic Metastasis
1
Head and Neck Neoplasms
1
Gallbladder Neoplasms
1
Diabetes Mellitus, Insulin-Dependent, 10
1
Cholangiocarcinoma
1
Carcinoma, Transitional Cell
1
Carcinoma, Squamous Cell
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
ruxolitinib
4
Cyclophosphamide
3
fludarabine phosphate
2
Whole-Body Irradiation
2
Tacrolimus
2
Peripheral Blood Stem Cell Transplantation
2
Cyclosporine
2
umbralisib
1
reparixin
1
itacitinib
1
iadademstat
1
fludarabine
1
fedratinib
1
decitabine and cedazuridine drug combination
1
canakinumab
1
Specimen Handling
1
Sirolimus
1
Panobinostat
1
Mycophenolic Acid
1
Methotrexate
1
Melphalan
1
INCB039110
1
Hyperbaric Oxygenation
1
Etoposide
1
CPI-0610
1
Busulfan
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Primary Myelofibrosis
×
avelumab
×
30 days
×
Clear all
No trials found.